Secondary Prevention

Assessing the Cost Effectiveness of an Incremental Lipid‐Lowering Therapy Approach After Coronary Artery Bypass Grafting Using Nationwide Data Stimulant Toxicity as Acute-on-Chronic Cardiovascular Death: How Cardiovascular Care Needs to Adapt Association Between Copayments and Attendance in Cardiac Rehabilitation: A Nationwide Analysis From the AACVPR Registry Association Between Lipoprotein(a) Testing, Lipid‐Lowering Therapy Intensification, and Low‐Density Lipoprotein Cholesterol Goal Attainment: Findings From the Veterans Affairs Health System Clopidogrel Versus Aspirin Monotherapy Beyond 1 Year After PCI: The Final 5-Year Results of the STOPDAPT-2 ACS and STOPDAPT-2 Total Cohort Statin Use and Recurrent Atherosclerotic Cardiovascular Disease Events in Patients With Coronary Artery Intervention: A Retrospective Analysis From a Large Health Care Network Long‐Term Risk of Stroke Recurrence: A  Competing Risk Analysis Based on the South London Stroke Register Response by Skaarup and Biering-Sørensen to Letter Regarding Article, “A Nationwide Factorial Randomized Trial of Electronic Nudges to Patients With Chronic Kidney Disease and Their General Practices for Increasing Guideline-Directed Medical Therapy: The NUDGE-CKD Trial” Recurrent Stroke in Patients With Cryptogenic Stroke and Left Ventricular Injury: The Cardiac Abnormalities in Stroke Prevention and Recurrence (CASPR) Study Heightened Risk of Myocardial Ischemia With Mental Stress Among Black Women Survivors of a Myocardial Infarction in Midlife